Ebitda Изменить Дата
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.8B 1.25B 2026-09
Baxter International USD 474M 165M 2026-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cytokinetics USD -160.3M 9.02M 2026-06
DBV Technologies USD -61.2M 15.3M 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
MannKind USD 2.47M 461K 2026-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Pfizer USD 6.36B 350M 2026-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
United Therapeutics USD 334.2M 20.8M 2026-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12